// COMPANY
Sofinnova Partners
// OVERVIEW
VC firm focused on life sciences investments.
Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
funding·StrictlyVC·SEPTEMBER 29, 2026
“Sofinnova Partners closed its oversubscribed fourth MD Start fund at €82 million ($93.3 million) to create six to eight new medtech companies in Europe and the U.S. over the next five years.”
Source→02
03
mention·The VC Corner·AUGUST 22, 2026
“"Sofinnova (75)"”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.